These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

467 related items for PubMed ID: 34159630

  • 21. HIV pre-exposure prophylaxis for adolescent girls and young women in Africa: from efficacy trials to delivery.
    Celum CL, Delany-Moretlwe S, Baeten JM, van der Straten A, Hosek S, Bukusi EA, McConnell M, Barnabas RV, Bekker LG.
    J Int AIDS Soc; 2019 Jul; 22 Suppl 4(Suppl Suppl 4):e25298. PubMed ID: 31328444
    [Abstract] [Full Text] [Related]

  • 22. Facilitators and barriers to HIV pre-exposure prophylaxis (PrEP) uptake through a community-based intervention strategy among adolescent girls and young women in Seme Sub-County, Kisumu, Kenya.
    Jackson-Gibson M, Ezema AU, Orero W, Were I, Ohiomoba RO, Mbullo PO, Hirschhorn LR.
    BMC Public Health; 2021 Jul 01; 21(1):1284. PubMed ID: 34210288
    [Abstract] [Full Text] [Related]

  • 23. Implementation strategies for integrating pre-exposure prophylaxis for HIV prevention and family planning services for adolescent girls and young women in Kenya: a qualitative study.
    Roche SD, Barnabee G, Omollo V, Mogaka F, Odoyo J, Bukusi EA, Morton JF, Johnson R, Celum C, Baeten JM, O'Malley G.
    BMC Health Serv Res; 2022 Mar 30; 22(1):422. PubMed ID: 35354456
    [Abstract] [Full Text] [Related]

  • 24. Baseline preferences for oral pre-exposure prophylaxis (PrEP) or dapivirine intravaginal ring for HIV prevention among adolescent girls and young women in South Africa, Uganda and Zimbabwe (MTN-034/IPM-045 study).
    Ngure K, Friedland BA, Szydlo DW, Roberts ST, Garcia M, Levy L, Akello CA, Reddy K, Palanee-Phillips T, Macdonald P, Siziba B, Soto-Torres L, Hosek S, Hillier SL, Nair G, Celum C, van der Straten A.
    PLoS One; 2023 Mar 30; 18(6):e0287525. PubMed ID: 37352296
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Qualitative characterizations of relationships among South African adolescent girls and young women and male partners: implications for engagement across HIV self-testing and pre-exposure prophylaxis prevention cascades.
    Holmes LE, Kaufman MR, Casella A, Mudavanhu M, Mutunga L, Polzer T, Bassett J, Van Rie A, Schwartz S.
    J Int AIDS Soc; 2020 Jun 30; 23 Suppl 3(Suppl 3):e25521. PubMed ID: 32603025
    [Abstract] [Full Text] [Related]

  • 28. Persistence of oral pre-exposure prophylaxis (PrEP) among adolescent girls and young women initiating PrEP for HIV prevention in Kenya.
    de Dieu Tapsoba J, Zangeneh SZ, Appelmans E, Pasalar S, Mori K, Peng L, Tao J, Drain P, Okomo G, Bii S, Mukabi J, Zobrist S, Brady M, Obanda R, Madiang DO, Cover J, Duerr A, Chen YQ, Obong'o C.
    AIDS Care; 2021 Jun 30; 33(6):712-720. PubMed ID: 32951437
    [Abstract] [Full Text] [Related]

  • 29. Patterns of HIV Pre-exposure Prophylaxis use Among Adolescent Girls and Young Women Accessing Routine Sexual and Reproductive Health services in South Africa.
    Martin CE, Cox LA, Nongena P, Butler V, Ncube S, Sawry S, Mullick S.
    J Adolesc Health; 2023 Dec 30; 73(6S):S81-S91. PubMed ID: 37953014
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Mandrax use, sexual risk, and opportunities for pre-exposure prophylaxis among out-of-school adolescent girls and young women in Cape Town, South Africa.
    Bonner CP, Browne FA, Carney T, Shangase N, Ndirangu JW, Myers B, Wechsberg WM.
    S Afr Med J; 2022 Apr 29; 112(5):341-346. PubMed ID: 35587247
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Oral pre-exposure prophylaxis preference, uptake, adherence and continuation among adolescent girls and young women in Kampala, Uganda: a prospective cohort study.
    Mayanja Y, Kamacooko O, Lunkuse JF, Muturi-Kioi V, Buzibye A, Omali D, Chinyenze K, Kuteesa M, Kaleebu P, Price MA.
    J Int AIDS Soc; 2022 May 29; 25(5):e25909. PubMed ID: 35543110
    [Abstract] [Full Text] [Related]

  • 37. How a menu of adherence support strategies facilitated high adherence to HIV prevention products among adolescent girls and young women in sub-Saharan Africa: a mixed methods analysis.
    Roberts ST, Mancuso N, Williams K, Nabunya HK, Mposula H, Mugocha C, Mvinjelwa P, Garcia M, Szydlo DW, Soto-Torres L, Ngure K, Hosek S.
    J Int AIDS Soc; 2023 Nov 29; 26(11):e26189. PubMed ID: 37936551
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Understanding and measuring uptake and coverage of oral pre-exposure prophylaxis delivery among adolescent girls and young women in sub-Saharan Africa.
    Dunbar MS, Kripke K, Haberer J, Castor D, Dalal S, Mukoma W, Mullick S, Patel P, Reed J, Subedar H, Were D, Warren M, Torjesen K.
    Sex Health; 2018 Nov 29; 15(6):513-521. PubMed ID: 30408431
    [Abstract] [Full Text] [Related]

  • 40. Continued attendance in a PrEP program despite low adherence and non-protective drug levels among adolescent girls and young women in Kenya: Results from a prospective cohort study.
    Tapsoba JD, Cover J, Obong'o C, Brady M, Cressey TR, Mori K, Okomo G, Kariithi E, Obanda R, Oluoch-Madiang D, Chen YQ, Drain P, Duerr A.
    PLoS Med; 2022 Sep 29; 19(9):e1004097. PubMed ID: 36095005
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.